This investigation was carried out To guage the prospective in the CPPs with tumor-concentrating on properties to deliver a cytotoxic payload to HCC cells. We explored utilizing a CXCR4-concentrating on peptide, T22, fused with cytotoxic peptide PE24, like a novel therapeutic method for CXCR4+ HCC cells. T22 was selected since the nanocarrier resul